• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of a new rapid test for influenza A and B viruses detection and pandemic (H1N1)2009 subtyping in respiratory samples

tetano

Editor, Senior Moderator
J Med Microbiol. 2011 Apr 1. [Epub ahead of print]
Evaluation of a new rapid test for influenza A and B viruses detection and pandemic (H1N1)2009 subtyping in respiratory samples.

L?v?que N, Talmud D, Renois F, Barbe C, Andr?oletti L.

1 Centre Hospitalier et Universitaire de Reims; IFR53/EA-4303, Facult? de M?decine;
Abstract

A new commercially available rapid influenza diagnostic test was evaluated for influenza A and B viruses detection in association with pandemic A(H1N1)2009 influenza virus subtyping in 106 nasopharyngeal samples. Comparatively to rRT-PCR assay, sensitivity and specificity for the pandemic A(H1N1)2009 influenza virus diagnosis were respectively 39.3% and 100%. This low sensitivity assessed from clinical samples indicates that this new RIDT has moderate clinical value for a first-line screening strategy of nasopharyngeal samples obtained from A(H1N1)2009 influenza virus suspect cases in daily virological diagnosis.

PMID: 21459910 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/21459910
 
Back
Top Bottom